Clinicopathologic Features of Gastrointestinal Tract Langerhans Cell Histiocytosis.

Langerhans cell histiocytosis adult gastrointestinal pediatric

Journal

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
ISSN: 1530-0285
Titre abrégé: Mod Pathol
Pays: United States
ID NLM: 8806605

Informations de publication

Date de publication:
17 Jun 2024
Historique:
received: 07 02 2024
revised: 21 05 2024
accepted: 11 06 2024
medline: 20 6 2024
pubmed: 20 6 2024
entrez: 19 6 2024
Statut: aheadofprint

Résumé

Gastrointestinal (GI) tract involvement by Langerhans cell histiocytosis (LCH) is rare and its clinicopathologic characteristics have only been described in case reports and small series. We reviewed hematoxylin and eosin- and CD1a, S100, and Langerin immunohistochemical-stained slides from 47 patients with well-documented demographic and clinical findings. Our cases included 8 children and 39 adults, with a mean follow-up of 63 months. All pediatric patients had concurrent multisystem LCH, presented with GI symptoms, and showed non-polypoid lesions. Seven (88%) showed multifocal GI disease, including five with multiple GI organ involvement. All sampled lesions from children exhibited infiltrative growth. More than half had died of the disease or manifested persistent LCH at last follow-up. Twenty-five of 39 (64%) adults had LCH involving only the GI tract (single-system), with the remaining 14 (36%) exhibiting multi-system disease. Adult single-system GI LCH was typically encountered incidentally on screening/surveillance endoscopy (72%). Most exhibited isolated colorectal involvement (88%) as a solitary polyp (92%), with a well-demarcated/noninfiltrative growth pattern (70%), and excellent prognosis (100%). In comparison, adult patients with multi-system LCH more frequently presented with GI symptoms (92%, P<0.001), non-colorectal GI site involvement (50%, P=0.02), multifocal GI lesions (43%, P=0.005), non-polypoid lesions (71%, P<0.001), infiltrative histologic growth pattern (78%, P=0.04), and persistent disease (57%, P<0.001). Adult multi-system LCH patients appear to exhibit similar clinicopathologic features to those of pediatric patients. These results demonstrate that adults with single-system LCH involving the GI tract have an excellent prognosis, while multi-system LCH occurring at any age carries an unfavorable prognosis. High-risk features of GI LCH include pediatric age, GI symptomatology, non-colorectal GI involvement, multifocal GI disease, non-polypoid lesions, and infiltrative growth pattern.

Identifiants

pubmed: 38897453
pii: S0893-3952(24)00123-6
doi: 10.1016/j.modpat.2024.100543
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100543

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Shaomin Hu (S)

Cleveland Clinic, Cleveland, OH.

Rondell P Graham (RP)

Mayo Clinic, Rochester, MN.

Won-Tak Choi (WT)

University of California, San Francisco, CA.

Kwun Wah Wen (KW)

University of California, San Francisco, CA.

Juan Putra (J)

Boston Children's Hospital, Boston, MA.

Wei Chen (W)

The Ohio State University Wexner Medical Center, Columbus, OH.

Jingmei Lin (J)

Indiana University, Indianapolis, IN.

Ivan A Gonzalez (IA)

Indiana University, Indianapolis, IN.

Nicole Panarelli (N)

Montefiore Medical Center, Bronx, NY.

Qiang Liu (Q)

Montefiore Medical Center, Bronx, NY.

Lei Zhao (L)

Brigham and Women's Hospital, Boston, MA.

Shunyou Gong (S)

Northwestern University Feinberg School of Medicine, Chicago, IL.

Melissa Mejia-Bautista (M)

Northwestern University Feinberg School of Medicine, Chicago, IL.

David J Escobar (DJ)

Northwestern University Feinberg School of Medicine, Chicago, IL.

Changqing Ma (C)

University of Pittsburg Medical Center, Pittsburg, PA.

Akram Shalaby (A)

University of Pittsburg Medical Center, Pittsburg, PA.

Xiaotang Du (X)

David Geffen School of Medicine at UCLA, Los Angeles, CA.

Liang-I Kang (LI)

Washington University, St. Louis, MO.

Wei Zhang (W)

University of Wisconsin School of Medicine and Public Health, Madison, WI.

Xiuxu Chen (X)

Loyola University Medical Center, Chicago, IL.

Xianzhong Ding (X)

Loyola University Medical Center, Chicago, IL.

Hannah H Chen (HH)

Tufts Medical Center, Boston, MA.

Zhan Ye (Z)

University of Kansas Medical Center, Kansas City, KS.

Maryam K Pezhouh (MK)

University of California, San Diego, CA.

Xiaoyan Liao (X)

University of Rochester, Rochester, NY.

Yongjun Liu (Y)

University of Washington Medical Center, Seattle, WA.

Zhaohai Yang (Z)

University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

Lindsay Alpert (L)

University of Chicago, Chicago, IL.

John Hart (J)

University of Chicago, Chicago, IL.

John R Goldblum (JR)

Cleveland Clinic, Cleveland, OH.

Daniela Allende (D)

Cleveland Clinic, Cleveland, OH.

Wei Zheng (W)

Emory University, Atlanta, GA.

Raul S Gonzalez (RS)

Emory University, Atlanta, GA.

Hanlin L Wang (HL)

David Geffen School of Medicine at UCLA, Los Angeles, CA.

Xuchen Zhang (X)

Yale School of Medicine, New Haven, CT.

Xiuli Liu (X)

Washington University, St. Louis, MO.

Teri Longacre (T)

Stanford University, Stanford, CA.

Maria Westerhoff (M)

University of Michigan, Ann Arbor, MI.

Yue Xue (Y)

Northwestern University Feinberg School of Medicine, Chicago, IL. Electronic address: Yue.Xue@UHhospitals.org.

Classifications MeSH